Definium Therapeutics, Inc. (DFTX) — Stock Score Summary

Definium Therapeutics, Inc. (DFTX) has a MoatMap StockRank of 44/100 based on Quality (32/100), Value (24/100), and Momentum (75/100) factor scores. The current signal is HOLD.

Definium Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing novel small molecule therapies for rare diseases. The company's competitive potential hinges on the successful advancement of its pipeline candidates through clinical trials, aiming to address critical unmet medical needs with innovative therapeutic approaches.

Key Financial Metrics

Price$23.48
Market Cap$2.6B
P/E (Forward)-14.47
Price/Book6.80
Return on Equity-94.7%
Return on Invested Capital-47.8%
Debt/Equity14.62
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-46M

Definium Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Definium Therapeutics, Inc.’s (DFTX) StockRank?
MoatMap’s StockRank for Definium Therapeutics, Inc. (DFTX) is 44/100, with a Hold signal. It is a composite of Quality (32), Value (24), and Momentum (75) factor ranks across MoatMap’s 19,000+ stock universe.
Does Definium Therapeutics, Inc. have an economic moat?
Definium Therapeutics, Inc. (DFTX) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Definium Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Definium Therapeutics, Inc. (DFTX) is Hold, based on a StockRank of 44/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Definium Therapeutics, Inc. in?
Definium Therapeutics, Inc. (DFTX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksDFTX deep dive reportAI ChampionsHow we score stocksSense-check another stock